Literature DB >> 7208146

Plasma alpha-ketoglutarate in urea cycle enzymopathies and its role as a harbinger of hyperammonemic coma.

M L Batshaw, M Walser, S W Brusilow.   

Abstract

Metabolic observations during early stages of hyperammonemia in two infants with ornithine transcarbamylase deficiency suggest that plasma alpha-ketoglutarate concentration ([alpha-KG]) becomes subnormal before the development of hyperammonemic coma. In one case, plasma [NH4+] remained normal until 40 days of age when it rose to 58 microM. However, this hyperammonemia was preceded by a fall in plasma [alpha-KG] to 15 microM at 27 days of age. It was only after severe hyperammonemia was established at 50 days of age that coma supervened. In the second case, plasma [alpha-KG] became subnormal (14 microM) 8 days before the rise in plasma ammonium concentration [NH4+] (52 microM) and 14 days before the onset of hyperammonemic coma. In eight patients with urea cycle enzymopathies, there was a highly significant (P less than 0.01) negative linear correlation between [NH4+] and [alpha-KG]. In patients with portal-systemic encephalopathy, there was a similar relationship between [NH4+] and [alpha-KG], although the absolute [alpha-KG] levels in these patients were normal (23 +/- 4 microM) while the patients were hyperammonemic (88 +/- 25 microM).

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7208146     DOI: 10.1203/00006450-198012000-00008

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  7 in total

Review 1.  Evidence of a vicious cycle in glutamine synthesis and breakdown in pathogenesis of hepatic encephalopathy-therapeutic perspectives.

Authors:  Milan Holecek
Journal:  Metab Brain Dis       Date:  2013-08-31       Impact factor: 3.584

2.  Enzymatic analysis of α-ketoglutaramate--a biomarker for hyperammonemia.

Authors:  Lenka Halámková; Shay Mailloux; Jan Halámek; Arthur J L Cooper; Evgeny Katz
Journal:  Talanta       Date:  2012-08-24       Impact factor: 6.057

3.  Hyperammonaemia-induced skeletal muscle mitochondrial dysfunction results in cataplerosis and oxidative stress.

Authors:  Gangarao Davuluri; Allawy Allawy; Samjhana Thapaliya; Julie H Rennison; Dharmvir Singh; Avinash Kumar; Yana Sandlers; David R Van Wagoner; Chris A Flask; Charles Hoppel; Takhar Kasumov; Srinivasan Dasarathy
Journal:  J Physiol       Date:  2016-10-23       Impact factor: 5.182

Review 4.  Acute metabolic encephalopathy: a review of causes, mechanisms and treatment.

Authors:  R Surtees; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

5.  Inhibitory effect of intravenous lysine infusion on urea cycle metabolism.

Authors:  T Kato; M Sano; N Mizutani
Journal:  Eur J Pediatr       Date:  1987-01       Impact factor: 3.183

Review 6.  Hepatic encephalopathy.

Authors:  Wissam Bleibel; Abdullah M S Al-Osaimi
Journal:  Saudi J Gastroenterol       Date:  2012 Sep-Oct       Impact factor: 2.485

7.  Plasma Krebs Cycle Intermediates in Nonalcoholic Fatty Liver Disease.

Authors:  Yana Sandlers; Rohan R Shah; Ryan W Pearce; Jaividhya Dasarathy; Arthur J McCullough; Srinivasan Dasarathy
Journal:  J Clin Med       Date:  2020-01-22       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.